Literature DB >> 7992919

Intrathecal magnesium sulfate protects the spinal cord from ischemic injury during thoracic aortic cross-clamping.

J I Simpson1, T R Eide, G A Schiff, J F Clagnaz, I Hossain, A Tverskoy, G Koski.   

Abstract

BACKGROUND: Paraplegia is a known complication after surgery on the descending thoracic aorta. Thoracic aortic cross-clamping causes an increase in proximal aortic and cerebrospinal fluid pressures. Sodium nitroprusside, though effectively decreasing proximal aortic pressure, has been implicated in worsening the incidence of paraplegia by further increasing cerebrospinal fluid pressure and decreasing distal blood pressure, thereby reducing spinal cord perfusion pressure. Intravenous administration of magnesium sulfate has been shown to offer some spinal cord protection when used with mild hypothermia. This study investigated the effect of intrathecal magnesium on the prevention of paraplegia when sodium nitroprusside is used to control proximal hypertension during thoracic aortic cross-clamping in a dog model of spinal cord ischemia.
METHODS: Two groups of eight dogs underwent thoracic aortic cross-clamping via a small thoracotomy incision for 45 min. Proximal, distal, and central venous pressures and cerebrospinal fluid pressures were monitored. Temperature was maintained at 36 degrees C. Sodium nitroprusside was used to control proximal hypertension. The control group received no magnesium sulfate, and a second group received 3 mg/kg intrathecal magnesium sulfate before thoracic aortic cross-clamping. The dogs were neurologically evaluated 24 h later by an observer blinded to the dogs' group. Spinal cord segments were obtained for histologic examination.
RESULTS: Proximal mean arterial pressure, cerebrospinal fluid pressure, spinal cord perfusion pressure, and central venous pressure were not statistically different between the two groups. Neurologic outcome, however, was statistically different between the groups. None of the eight dogs in the magnesium group had any measurable neurologic injury, in contrast to the control group, in which seven of the eight dogs had severe neurologic injury (P < 0.005). Post mortem histologic data supported these findings.
CONCLUSIONS: Intrathecal magnesium can prevent spinal cord injury despite markedly negative spinal cord perfusion pressure during thoracic aortic cross-clamping in a canine model of spinal cord ischemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7992919

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  15 in total

Review 1.  Trends in neuroanaesthesia.

Authors:  J E Cottrell
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

2.  Delayed paraplegia after spinal cord ischemic injury requires caspase-3 activation in mice.

Authors:  Manabu Kakinohana; Kotaro Kida; Shizuka Minamishima; Dmitriy N Atochin; Paul L Huang; Masao Kaneki; Fumito Ichinose
Journal:  Stroke       Date:  2011-06-23       Impact factor: 7.914

3.  Could adding magnesium as adjuvant to ropivacaine in caudal anaesthesia improve postoperative pain control?

Authors:  H Birbicer; N Doruk; I Cinel; S Atici; D Avlan; E Bilgin; U Oral
Journal:  Pediatr Surg Int       Date:  2006-09-22       Impact factor: 1.827

4.  Effects of adjunct intrathecal magnesium sulfate to bupivacaine for spinal anesthesia: a randomized, double-blind trial in patients undergoing lower extremity surgery.

Authors:  Gholamreza Khalili; Mohsen Janghorbani; Parvin Sajedi; Gholamhossein Ahmadi
Journal:  J Anesth       Date:  2011-09-18       Impact factor: 2.078

Review 5.  Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness.

Authors:  K W Muir
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

6.  Hypothermia prevents biphasic glutamate release and corresponding neuronal degeneration after transient spinal cord ischemia in the rat.

Authors:  T Ishikawa; M Marsala
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

7.  Augmented bupivacaine spinal anaesthesia in postoperative analgesia.

Authors:  Nq Okojie; It Ekwere; Co Imarengiaye
Journal:  J West Afr Coll Surg       Date:  2012-07

8.  Effects of adding magnesium to bupivacaine and fentanyl for spinal anesthesia in knee arthroscopy.

Authors:  Hüban Dayioğlu; Zehra N Baykara; Asena Salbes; Mine Solak; Kamil Toker
Journal:  J Anesth       Date:  2009-02-22       Impact factor: 2.078

9.  Magnesium sulfate treatment in experimental spinal cord injury: emphasis on vascular changes and early clinical results.

Authors:  Erkan Kaptanoglu; Etem Beskonakli; Ihsan Solaroglu; Asuman Kilinc; Yamac Taskin
Journal:  Neurosurg Rev       Date:  2003-05-29       Impact factor: 3.042

10.  Adding different doses of intrathecal magnesium sulfate for spinal anesthesia in the cesarean section: A prospective double blind randomized trial.

Authors:  Mitra Jabalameli; Seyed Hamid Pakzadmoghadam
Journal:  Adv Biomed Res       Date:  2012-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.